AGA Family of Websites:

About AGA

AGA Corporate Roundtable

The AGA Corporate Roundtable engages corporate partners and AGA leadership in dialogue regarding innovations in practice, clinical and research advances, public policy, and other issues that impact the future of gastroenterology and hepatology care. Our goal is to work together to better serve the GI community and improve care for digestive disease patients.

2023-2024 AGA Corporate Roundtable Members

Thank you to our corporate roundtable members for your shared commitment to advancing GI. Roundtable fees support the AGA Research Foundation.

Bristol Myers Squibb
Eli Lilly and Company
Ferring Pharmaceuticals
Pfizer, Inc.
Salix Pharmaceuticals
Takeda Pharmaceuticals U.S.A., Inc.


Boston Scientific
Exact Sciences
Genentech, Inc
Geneoscopy, Inc.
Ironwood Pharmaceuticals
Janssen Biotech, Inc.
Merck & Co., Inc.
Novo Nordisk
Phathom Pharmaceuticals Inc.
Sandoz, Inc (A Novartis Division)

As of Jan. 30, 2024

Join the roundtable

AGA welcomes our corporate partners to join the roundtable.

Let's partner

We want to work with your company on future initiatives.

Membership to the corporate roundtable supports the AGA Research Foundation. Benefits of participation in the roundtable include:

  • Access to AGA leadership and other industry leaders.
  • Up to date information on the latest news in the field.
  • Opportunity to share your insights and opinions.
  • Visibility at DDW events.
  • Recognition in AGA communications including journals, website and newsletters
Roundtable members at all levels are invited to participate in annual joint meetings. These meetings provide a unique opportunity for interaction within the GI community, enabling members to share information with each other and hear speakers address common topics of interest. For further information and to join the AGA Corporate Roundtable, please contact Harmony Excellent at 301-272-1602 or .